Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome
Authors
Keywords
-
Journal
GYNECOLOGICAL ENDOCRINOLOGY
Volume 33, Issue 7, Pages 529-533
Publisher
Informa UK Limited
Online
2017-03-17
DOI
10.1080/09513590.2017.1296425
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of insulin and selected adipocytokines in patients with polycystic ovary syndrome (PCOS) – a literature review
- (2015) Katarzyna Ożegowska et al. Ginekologia Polska
- Plasma Visfatin Levels in Adolescents with Polycystic Ovary Syndrome: A Prospective Case-Control Study
- (2015) Ülker Gümüş et al. Journal of Pediatric and Adolescent Gynecology
- Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity
- (2014) Samantha Cassar et al. CLINICAL ENDOCRINOLOGY
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2013) EUROPEAN HEART JOURNAL
- Serum visfatin levels in women with polycystic ovary syndrome
- (2012) Nilgün Güdücü et al. GYNECOLOGICAL ENDOCRINOLOGY
- Adipokines, Insulin Resistance and Hyperandrogenemia in Obese Patients with Polycystic Ovary Syndrome: Cross-Sectional Correlations and the Effects of Weight Loss
- (2012) Nikolaos Spanos et al. Obesity Facts
- Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome
- (2011) Taina K. Lajunen et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Expression of visfatin mRNA in peripheral blood mononuclear cells is not correlated with visfatin mRNA in omental adipose tissue in women with polycystic ovary syndrome
- (2011) K.-M. Seow et al. HUMAN REPRODUCTION
- Plasma visfatin level in women with polycystic ovary syndrome
- (2010) Emre Dİkmen et al. GYNECOLOGICAL ENDOCRINOLOGY
- Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review
- (2010) Panagiotis Peitsidis et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Noninvasive methods for assessing early markers of atherosclerosis: the role of body composition and nutrition
- (2009) Kimon Stamatelopoulos et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS
- (2009) Bulent O Yildiz et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Nuclear Factor- B Induction by Visfatin in Human Vascular Endothelial Cells: Its role in MMP-2/9 production and activation
- (2008) R. Adya et al. DIABETES CARE
- Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?
- (2008) Evanthia Diamanti-Kandarakis et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Plasma visfatin levels in normal weight women with polycystic ovary syndrome
- (2008) Dimitrios Panidis et al. European Journal of Internal Medicine
- Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome
- (2008) Mesut Ozkaya et al. FERTILITY AND STERILITY
- Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1
- (2008) Bin Liu et al. GYNECOLOGICAL ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now